EDWARDS LIFESCIENCES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.94 USD | -0.59% |
|
-4.81% | +12.71% |
| Apr. 17 | Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 | MT |
| Apr. 17 | Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating | MT |
Presenter SpeechLarry Biegelsen (Analysts)All right. Good morning, everyone. I'm Larry Biegels...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-04-25
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.45
USD
Average target price
94.48
USD
Spread / Average Target
+9.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.71% | 52.04B | |
| +2.64% | 207B | |
| +1.80% | 175B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B | |
| +3.97% | 26.09B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Transcript : Edwards Lifesciences Corporation Presents at 14th Annual Wells Fargo Securities Healthcare Conference, Sep-04-2019 09
